Risks and benefits of phase 1 oncology trials in the era of personalized medicine

被引：1
|
作者：
Chakiba, C. [1 ]
Grellety, T. [1 ]
Cousin, S. [1 ]
Italiano, A. [1 ]
机构：
[1] Inst Bergonie, Med Oncol, Bordeaux, France
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw387.9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1372P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Risks and benefits of phase 1 oncology trials in the era of personalized medicine
    Chakiba, Camille
    Grellety, Thomas
    Cousin, Sophie
    Italiano, Antoine
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Risks and benefits of phase 1 oncology trials, revisited
    Kurzrock, R
    Benjamin, RS
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (09): : 930 - 932
  • [3] Risks and benefits of phase 1 oncology trials, 1991 through 2002
    Horstmann, E
    McCabe, MS
    Grochow, L
    Yamamoto, S
    Rubinstein, L
    Budd, T
    Shoemaker, D
    Emanuel, EJ
    Grady, C
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (09): : 895 - 904
  • [4] Descriptions of benefits and risks in consent forms for phase 1 oncology trials
    Horng, S
    Emanuel, EJ
    Wilfond, B
    Rackoff, J
    Martz, K
    Grady, C
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (26): : 2134 - 2140
  • [5] Risks and benefits of phase 1 oncology trials, 2001 through 2012.
    Fukuda, Yoko Korenaga
    Huang, Erich
    Finnigan, Shanda
    Ivy, S. Percy
    Rubinstein, Larry
    Takebe, Naoko
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Clinical trials in the era of personalized oncology
    Maitland, Michael L.
    Schilsky, Richard L.
    CA-A CANCER JOURNAL FOR CLINICIANS, 2011, 61 (06) : 365 - 381
  • [7] Clinical Trials and Personalized Medicine in Oncology?
    Arnold, Dirk
    Bokemeyer, Carsten
    ONKOLOGIE, 2010, 33 : 25 - 29
  • [8] Phase I oncology trials: risks and benefits vary by trial type
    Reactions Weekly, 2005, 1042 (1) : 5 - 5
  • [9] Communication about the risks and benefits of phase I pediatric oncology trials
    Hazen, Rebecca A.
    Zyzanski, Stephen
    Baker, Justin N.
    Drotar, Dennis
    Kodish, Eric
    CONTEMPORARY CLINICAL TRIALS, 2015, 41 : 139 - 145
  • [10] Revisiting the Ethics of Phase 1 Oncology Trials in the Era of Precision Medicine: A Systematic Review
    Mackley, M.
    Fernandez, N. R.
    Fletcher, B.
    Woolcott, C.
    Fernandez, C. V.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S433 - S433
12345